# A Study to Test How Well Different Doses of BI 3810477 Are Tolerated by Healthy Men

> **NCT06631430** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 24 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** BI 3810477
- **DRUG:** BI 3810477
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06631430
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-10-30
- **Primary completion:** 2025-06-12
- **Final completion:** 2025-06-12
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2025-06-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06631430

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06631430, "A Study to Test How Well Different Doses of BI 3810477 Are Tolerated by Healthy Men". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06631430. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*